R.E.S.P.O.N.D. Toolkit:

Opioid-related morbidity and mortality is a public health emergency strongly related prescription opioid use. Pharmacist are well positioned to reduce risks associated with opioid prescriptions and serve as a resource for other harms reduction activities. RESPOND - Resources Encouraging Safe Prescription Opioid and Naloxone Dispensing – is intended to help community pharmacists identify patients for whom an opioid prescription may present a safety risk, communicate more effectively with patients at the point of care, and coordinate with prescribers to maximize patient safety in the use of prescription opioid pain relievers.

This course is presented in three parts. The first will provide background information on the history and current status of the opioid epidemic in the United States. The second will focus on the history and recommended strategies for use of Prescription Drug Monitoring Programs (PDMPs) in community pharmacists’ daily workflow; the development and diffusion of PDMPs across the country has greatly enhanced the ability of pharmacists to screen for potential hazardous opioid prescribing. The third will provide tools and strategies for identifying at-risk patients and facilitating supportive, effective communication with prescribers and patients around opioid safety.

Accreditation Council for Pharmacy Education Information:

This program has been planned and implemented in accordance with the policies of the Accreditation Council for Pharmacy Education through the sponsorship of OSU College of Pharmacy. The OSU College of Pharmacy is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Upon completion of this activity, participants will receive a Certificate of Completion, and a Statement of Credit shall be uploaded to CPE Monitor. Completion requires 1) Registration for the course 2) Completion of all modules and 3) Passing a final exam with 80% or higher and 4) Completion of the program evaluation.

At the completion of this activity the participant will be able to:
1) Detail risk factors related to opioid overdose
2) Define "corresponding responsibility" and the pharmacist's role in addressing the opioid epidemic
3) Explain the history and present use of Prescription Drug Monitoring Programs (PDMP)
4) Review the recommendations for pharmacist use of the PDMP as part of a safe medication screening process
5) Outline PDMP-integrated workflow tips
6) Detail recommendations for positive, effective communication with prescribers and patients

UAN: 0036-0000-22-029-H01-P
Target Audience: Pharmacists liscensed in Oregon
Activity Type: Knowledge
Activity Release Date: 9/21/2022
Activity Expiration Date: 9/21/2025
Faculty/Contributors: Dan Hartung, PharmD, MPH; Nicole O'Kane, PharmD; Deborah Cohen, PhD; Adriane Irwin, MS, PharmD, BCACP; Christi Hildebran, LMSW, CADC III; Tyler Havlin, CPHQ; Kirbee Jonston, MPH; Kevin Novak, MS; Jody Carson, RN, MSW, CPHQ; Jen Hall, MPH; David Cameron; Lindsey Alley, MS; Sarah Haverly, MS, PhD(c)
Declarations: None of the contributors, designers, or peer reviewers for this course have any financial relationships with ineligible companies to disclose